ProKidney Statistics
Total Valuation
ProKidney has a market cap or net worth of $511.87 million. The enterprise value is $1.23 billion.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ProKidney has 291.66 million shares outstanding. The number of shares has increased by 32.24% in one year.
| Current Share Class | 127.97M |
| Shares Outstanding | 291.66M |
| Shares Change (YoY) | +32.24% |
| Shares Change (QoQ) | +66.22% |
| Owned by Insiders (%) | 20.96% |
| Owned by Institutions (%) | 35.80% |
| Float | 70.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.09, with a Debt / Equity ratio of 0.01.
| Current Ratio | 17.09 |
| Quick Ratio | 16.36 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15,099.10 |
Financial Efficiency
Return on equity (ROE) is -31.34% and return on invested capital (ROIC) is -21.43%.
| Return on Equity (ROE) | -31.34% |
| Return on Assets (ROA) | -20.37% |
| Return on Capital (ROIC) | -21.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$279,810 |
| Employee Count | 163 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ProKidney has paid $491,000 in taxes.
| Income Tax | 491,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.42% in the last 52 weeks. The beta is 1.31, so ProKidney's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | +1.42% |
| 50-Day Moving Average | 1.89 |
| 200-Day Moving Average | 2.17 |
| Relative Strength Index (RSI) | 48.18 |
| Average Volume (20 Days) | 431,743 |
Short Selling Information
The latest short interest is 10.34 million, so 3.55% of the outstanding shares have been sold short.
| Short Interest | 10.34M |
| Short Previous Month | 10.74M |
| Short % of Shares Out | 3.55% |
| Short % of Float | 14.69% |
| Short Ratio (days to cover) | 24.49 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -150.99M |
| Pretax Income | -34.94M |
| Net Income | -45.61M |
| EBITDA | -145.99M |
| EBIT | -150.99M |
| Earnings Per Share (EPS) | -$0.56 |
Full Income StatementBalance Sheet
The company has $406.81 million in cash and $6.44 million in debt, giving a net cash position of $400.37 million or $1.37 per share.
| Cash & Cash Equivalents | 406.81M |
| Total Debt | 6.44M |
| Net Cash | 400.37M |
| Net Cash Per Share | $1.37 |
| Equity (Book Value) | 443.47M |
| Book Value Per Share | -7.66 |
| Working Capital | 405.04M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$127.56 million and capital expenditures -$5.57 million, giving a free cash flow of -$133.14 million.
| Operating Cash Flow | -127.56M |
| Capital Expenditures | -5.57M |
| Free Cash Flow | -133.14M |
| FCF Per Share | -$0.46 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |